CogState Limited (ASX: CGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CogState Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CogState Limited (ASX: CGS)
Latest News
Healthcare Shares
2 ASX healthcare shares to buy that you've not heard of: expert
Technology Shares
Here's how ASX tech shares fared in September
Share Gainers
These were the 5 best-performing ASX All Ords shares in September
Share Gainers
Why Cogstate, Global Lithium, Premier, and Woodside shares are charging higher
Healthcare Shares
The Cogstate share price is rocketing again, up another 27% on Thursday
Share Gainers
Why Cogstate, Mayne Pharma, Race Oncology, and Whitehaven Coal are charging higher
Healthcare Shares
Why is the CogState share price rocketing 61% higher today?
Technology Shares
Top broker says this ASX tech share has over 30% upside
Earnings Results
3 ASX All Ordinaries shares being sold off following FY22 results
Healthcare Shares
CogState (ASX:CGS) share price crashes 20% on quarterly update
Healthcare Shares
CogState (ASX:CGS) share price rockets 9% on record quarter
Broker Notes
2 small cap ASX shares with exciting growth potential: experts
Frequently Asked Questions
-
No, Cogstate does not pay dividends at this stage.
-
Cogstate Ltd listed on the ASX on 13 February 2004.
CGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CogState Limited
Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.
The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment.
Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.